Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Human Genome Sequencing Center Clinical Lab, |
RCV001258110 | SCV001434975 | likely pathogenic | Li-Fraumeni syndrome | 2018-10-08 | criteria provided, single submitter | clinical testing | This c.272G>A (p.Trp91*) variant in the TP53 gene is predicted to introduce a premature translational termination codon. This variant has been reported as a somatic change in multiple tumor tissues in the COSMIC Database. It has not been reported before in patients or in the general population according to genomAD. Therefore, this c.272G>A (p.Trp91*) variant in the TP53 gene is classified as likely pathogenic. |
Labcorp Genetics |
RCV001258110 | SCV003787079 | pathogenic | Li-Fraumeni syndrome | 2024-09-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp91*) in the TP53 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TP53 are known to be pathogenic (PMID: 20522432). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of TP53-related conditions (PMID: 31060593). ClinVar contains an entry for this variant (Variation ID: 979079). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003473842 | SCV004204280 | pathogenic | Adrenocortical carcinoma, hereditary | 2022-05-05 | criteria provided, single submitter | clinical testing |